Twitter Facebook LinkedIn YouTube

Videos Tagged: pharmaceutical

New Listing: GreenStar Biosciences (CSE:GSTR)
New Listing: GreenStar Biosciences (CSE:GSTR)
Willow Biosciences and Noramco announce joint development of biosynthesis platform for cannabidiol
Willow Biosciences and Noramco announce joint development of biosynthesis platform for cannabidiol
Benchmark Botanics signs letter of intent with China-based Zejiang Yatai Pharmaceutical to advance CBD products
Benchmark Botanics signs letter of intent with China-based Zejiang Yatai Pharmaceutical to advance CBD products
New Listing: Willow Biosciences (CSE:WLLW)
New Listing: Willow Biosciences (CSE:WLLW)
New Listing: Vireo Health International (CSE:VREO)
New Listing: Vireo Health International (CSE:VREO)
Valeo Pharma Inc. (CSE:VPH) New Listing
Valeo Pharma Inc. (CSE:VPH) New Listing
FSD Pharma signs non-binding LOI with Solarvest BioEnergy to develop and test pharma-grade cannabinoids from algae
FSD Pharma signs non-binding LOI with Solarvest BioEnergy to develop and test pharma-grade cannabinoids from algae
Organic Flower Investments Group (CSE:SOW) New Listing
Organic Flower Investments Group (CSE:SOW) New Listing
Medexus Pharmaceuticals (TSXV:MDP) New Listing
Medexus Pharmaceuticals (TSXV:MDP) New Listing
FSD Pharma Inc. has appointed Rupert Haynes as Chief Executive Officer
FSD Pharma Inc. has appointed Rupert Haynes as Chief Executive Officer
FSD Pharma, a licensed cannabis producer, adds high level government relations executive, David Urban to Board of Directors
FSD Pharma, a licensed cannabis producer, adds high level government relations executive, David Urban to Board of Directors
FSD Pharma signs binding letter of intent to acquire NASDAQ-listed Therapix Biosciences, a developer of cannabinoid-based treatments
FSD Pharma signs binding letter of intent to acquire NASDAQ-listed Therapix Biosciences, a developer of cannabinoid-based treatments
North Bud Farms (CSE:NBUD) New Listing
North Bud Farms (CSE:NBUD) New Listing
Callitas Health Inc (CSE:LILY) has signed a consulting agreement with BFS Innovations and Pure Leaf Group
Callitas Health Inc (CSE:LILY) has signed a consulting agreement with BFS Innovations and Pure Leaf Group
Graphene 3D Lab (TSXV:GGG) Entered into a Technology Transfer Agreement with “Industrial Partner”
Graphene 3D Lab (TSXV:GGG) Entered into a Technology Transfer Agreement with “Industrial Partner”
HLS Therapeutics Inc. (TSXV:HLS) New Listing
HLS Therapeutics Inc. (TSXV:HLS) New Listing
Naturally Splendid announced the sale of its 51% majority interest in POS BPC Mfg. Corp.
Naturally Splendid announced the sale of its 51% majority interest in POS BPC Mfg. Corp.
Naturally Splendid (TSXV: NSP) will be applying to become a Licensed Dealer of cannabis extracts under Canadian regulations
Naturally Splendid (TSXV: NSP) will be applying to become a Licensed Dealer of cannabis extracts under Canadian regulations
NanoSphere Health Sciences Inc. (CSE:NSHS) New Listing
NanoSphere Health Sciences Inc. (CSE:NSHS) New Listing
Eviana Health Corporation (CSE:EHC) New Listing
Eviana Health Corporation (CSE:EHC) New Listing
CannTrust Holdings (CSE: TRST) New Listing
CannTrust Holdings (CSE: TRST) New Listing
Lotus Ventures (CSE:J) Announced a Non-Brokered Private Placement
Lotus Ventures (CSE:J) Announced a Non-Brokered Private Placement
MedReleaf Corp. (TSX: LEAF) New Listing
MedReleaf Corp. (TSX: LEAF) New Listing
CanniMed Therapeutics (TSX: CMED) New Listing
CanniMed Therapeutics (TSX: CMED) New Listing
Alliance Growers (CSE:ACG) is in the final stage of negotiations with WFS Pharmagreen
Alliance Growers (CSE:ACG) is in the final stage of negotiations with WFS Pharmagreen
M Pharmaceutical (CSE: MQ) rebrands itself under the mantra “Better Health. Better Life.”
M Pharmaceutical (CSE: MQ) rebrands itself under the mantra “Better Health. Better Life.”
M Pharmaceutical's (CSE:MQ) Dr. Martin Mintchev video interview with InvestmentPitch
M Pharmaceutical's (CSE:MQ) Dr. Martin Mintchev video interview with InvestmentPitch
Mackie Research has initiated coverage on Medicure Inc. (TSXV: MPH)
Mackie Research has initiated coverage on Medicure Inc. (TSXV: MPH)
San Francisco-based Merriman Capital has initiated coverage on OptimizeRx Corporation (OTCQB: OPRX)
San Francisco-based Merriman Capital has initiated coverage on OptimizeRx Corporation (OTCQB: OPRX)
BioSyent (TSXV: RX) subject of a StockPotentials report by Toronto-based eResearch Corporation
BioSyent (TSXV: RX) subject of a StockPotentials report by Toronto-based eResearch Corporation